Gastric cancer ranks as the fifth most common malignant tumor worldwide and is the third most common cause of cancer-related death. For advanced gastric cancer (AGC), neoadjuvant chemotherapy (NAC) can reduce its stage, increase the rate of radical resection, improve response to treatment, reduce the risk of local recurrence and improve survival rate. Regional arterial infusion chemotherapy (RAIC) is a form of NAC that involves directly injecting chemotherapeutic drugs into the tumor site through the tumor-feeding artery. RAIC increases the local drug concentration around the tumor, thereby improving the therapeutic responses and reducing the adverse effects of the drugs. In recent years, RAIC has attracted increasing attention. This article summarizes the basic principles, procedure, chemotherapy regimens, adverse drug reactions and complications, clinical applications and response evaluation of RAIC in the treatment of AGC.
Introduction
Gastric cancer ranks as the fifth most common malignant tumor worldwide and is the third most common cause of cancer-related death [1] . Currently, surgical resection is still considered the only cure for gastric cancer. However, the symptoms of gastric cancer are not obvious. Most gastric cancers are diagnosed in the late-stage, when surgical treatments are not available options. Neoadjuvant chemotherapy (NAC) improves the rate of radical resection and long-term survival
RAIC Procedure
The Seldinger technique is commonly used to puncture the right femoral artery. Anangiographic catheter is placed in the celiac artery for digital subtraction angiography. A tumor-feeding artery (left gastric artery, right gastric artery, left gastroepiploic artery, right gastroepiploic artery, or gastroduodenal artery) is identified. Then, the tumor-feeding artery is subject to ultra-selective intubation and angiography. Once a clear range of lesions, blood supply, and other conditions are determined, chemotherapy drugs are slowly injected (Figure 1 ).
Puncturing the femoral artery is a convenient operation with a high success rate. The method is mainly used for short-term RAIC. Puncturing the axillary and subclavian arteries requires a relatively more complex technique. Because these types of punctures affect the activities of the patients, they are mainly used for long-term, intermittent chemotherapy (implantable port system) to avoid repeated punctures [11] [12] . 
Chemotherapy Regimens
When performing RAIC, physicians should choose concentration-dependent and tumor-sensitive drugs, use drugs of different mechanisms of action in combination, and avoid drugs with similar toxicity or cumulative toxicity to a same organ. Common clinical chemotherapy drugs include cisplatin, oxaliplatin, mitomycin, adriamycin, epirubicin, docetaxel, raltitrexed, and fluorouracil. There is currently no standard RAIC chemotherapy regimen, and physicians generally use drugs employed for systemic intravenous NAC. Commonly used chemotherapy regimens are shown in the following table (Table 1) .
Treatment regimens vary from region to region. Among these regimens, those based on fluorouracil and platinum are very important [13] [14] . The dose of chemotherapeutic drug for RAIC is generally decided based on that of systemic chemotherapy and is adjusted according to the patient's body surface area and disease condition.
Adverse Drug Reactions and Complications
With the administration of RAIC, chemotherapy drugs will also reach the entire body though the blood circulation and act as systemic chemotherapy [3] [7] [9] [15]. The adverse drug reactions of RAIC are similar to those of systemic chemotherapy but to a lesser extent [7] . The major toxicity was bone marrow suppression; other side effects included appetite loss, nausea and vomiting [9] . Most bone marrow toxicities, appetite loss, nausea and vomiting were acceptable.
Complications related to arterial puncture and intubation include hematoma at Vasovagal reflexes [24] manifest as a sudden drop in blood pressure, reduced heart rate, paleness, sweating, slow breathing, and disturbance of consciousness when the arterial sheath is removed. Once these symptoms occurred, emergency measures should be initiated, including maintaining the patient in the supine position, rapidly replenishing isotonic saline, and intravenous injection of atropine and dopamine.
Clinical Applications

Preoperative Chemotherapy
The concept of NAC was proposed in 1982 [25] . Wilke et al. [15] [30]. Tao et al. [29] studied the effects of preoperative RAIC in inducing apoptosis and inhibiting the growth of gastric cancer cells. A total of 110 cases of GC and 68 cases of metastatic lymph nodes with or without RAIC were adopted. The apoptotic index in the RAIC treatment group was significantly increased compared with the untreated group, whereas the proliferation index in the RAIC treatment group was significantly reduced compared with the untreated group.
A postoperative survey demonstrated that the 5-year survival rate of GC patients in the RAIC group was significantly increased compared with the untreated group. Wu et al. [7] analyzed 178 AGCs receiving short-term neoadjuvant EOX chemotherapy. The postoperative pathological response rate was 46.1%, and the complete remission rate was 2.2%. Pathological response and tumor differentiation are significantly correlated with the modes of chemotherapy administration (intravenous and arterial regional perfusion chemotherapy). The 3-year overall survival (OS) and recurrence-free survival (RFS) rates were 67% and 53%, respectively. Compared with the intravenous chemotherapy group, the RAIC group exhibited a better median RFS. In a study by He et al. [ 
Postoperative Chemotherapy
Studies have demonstrated that postoperative chemotherapy can reduce the risk of local recurrence and metastasis and improve survival rates [35] [36] [37] . You et al. [35] 
Response Evaluation
A therapeutic response evaluation of RAIC is crucial for selecting the next treatment regimen. Medical imaging still plays an important role in response Disease-free survival, time to progression, and progression-free survival are main indicators to evaluate efficacy. However, the survival time is recorded after the end of treatment. Its role together with other prognostic indicators of efficacy in the adjustment of the current treatment options and the prediction longterm survival cannot be ignored.
The pathological residue rate of surgically resected specimens after chemotherapy is a relatively objective method to determine the curative effect of NAC.
However, in the actual practice of pathological evaluation, it is still difficult to accurately determine the tumor range before chemotherapy and the residual tumor rate.
In addition, biomarkers can also be used as indicators of efficacy [54] - [60] .
In short, standards for clinical evaluation of NAC for gastric cancer are lacking. Combining various evaluation indicators may help to improve the accuracy of the evaluation.
Conclusion
In conclusion, RAIC involves directly delivering chemotherapy drugs to tumor RAIC, as a treatment method of AGC, will be gradually standardized, and more AGC patients will benefit.
